CanSino Biologics Inc. (SEHK:6185) announces a share repurchase program. Under the program, the company will repurchase up to CNY 300 million worth of its class A shares. The shares will be repurchased at a maximum price of CNY 446.78 per share. The purpose of the program is to improve the company's long-term incentive mechanism, mobilizing the enthusiasm of the company's management personnel, core employees, and enhancing team cohesion and competitiveness, so as to effectively promote the long-term development of the company. The repurchased shares will be used for employee stock ownership plans or equity incentives. The program will be funded from internal funds of the company. The program will run for 12 months from the date of approval by the board.

On August 26, 2022, the company announced that it has adjusted the share repurchase price from CNY 446.78 per share to CNY 445.98 per share.